Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05238558
Title Safety and Immune Response to FMPV-1
Recruitment Active, not recruiting
Gender male
Phase Phase I
Variant Requirements No
Sponsors Hubro Therapeutics AS
Indications

colorectal cancer

Therapies

FMPV-1 + Sargramostim

Age Groups: adult | senior
Covered Countries


No variant requirements are available.